Charles Ayemoba was previously a Pre-Doctoral Trainee of Biomedical Research Technologies at Chobanian and Avedisian School of Medicine. He is now a Staff Research Associate at the University of California, San Francisco. Charles graduated from the University of Illinois at Urbana-Champaign with a bachelors degree in Molecular and Cellular Biology, and then went on to attend Chobanian and Avedisian School of Medicine and received a Masters in Biotechnology.
Predoctoral Trainee (previously held)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Biomedical Research Technologies
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Toboz P, Amiri M, Tabatabaei N, Dufour CR, Kim SH, Fillebeen C, Ayemoba CE, Khoutorsky A, Nairz M, Shao L, Pajcini KV, Kim KW, Giguère V, Oliveira RL, Constante M, Santos MM, Morales CR, Pantopoulos K, Sonenberg N, Pinho S, Tahmasebi S. The amino acid sensor GCN2 controls red blood cell clearance and iron metabolism through regulation of liver macrophages. Proc Natl Acad Sci U S A. 2022 Aug 30; 119(35):e2121251119. PMID: 35994670; PMCID: PMC9436309; DOI: 10.1073/pnas.2121251119;
Shi Y, Dincheva-Vogel L, Ayemoba CE, Fung JP, Bergamaschi C, Pavlakis GN, Farzaneh F, Gaensler KML. IL-15/IL-15Ra/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. Blood Adv. 2018 11 27; 2(22):3177-3192. PMID: 30482760; PMCID: PMC6258921; DOI: 10.1182/bloodadvances.2018019026;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.